Your shopping cart is currently empty

IBS008738 is an effective TAZ activator that stabilises TAZ and increases unphosphorylated TAZ levels in C2C12 cells, upregulates MyoD-dependent gene transcription, promotes muscle repair in injury models, and prevents muscle atrophy.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $48 | - | In Stock | |
| 5 mg | $124 | - | In Stock | |
| 10 mg | $207 | - | In Stock | |
| 25 mg | $456 | - | In Stock | |
| 50 mg | $788 | - | In Stock | |
| 1 mL x 10 mM (in DMSO) | $136 | - | In Stock |
| Description | IBS008738 is an effective TAZ activator that stabilises TAZ and increases unphosphorylated TAZ levels in C2C12 cells, upregulates MyoD-dependent gene transcription, promotes muscle repair in injury models, and prevents muscle atrophy. |
| In vitro | IBS008738 promotes myogenesis in C2C12 cells within the concentration range of 1-10 μM, with the most significant effect observed at 10 μM. The compound exhibits optimal efficacy when administered during the initial 24 hours of differentiation, markedly enhancing the expression of myogenin and MyoD [1]. IBS008738 facilitates myogenesis and muscle repair by stabilizing TAZ and strengthening the interaction between TAZ and MyoD, thereby promoting the transcription of myogenesis-related genes [1]. Treatment with IBS008738 (10 μM, 24 hours) elevates interleukin-10 (IL-10) levels in C2C12 cells [2]. |
| In vivo | In the mouse model of myocardial toxin-induced muscular injury, IBS008738 (3 nmol) promoted muscle regeneration and increased the number of central nucleated muscle fibers [1]. In the dexamethasone-induced muscular atrophy mouse model, IBS008738 (30 μM, 100 μL) prevented muscular atrophy and increased the cross-sectional area of muscle fibers and protein synthesis [1]. In the traumatic brain injury (TBI) mouse model, IBS008738 (30 μM, 100 μL, intramuscular injection, immediately and on day 2 after TBI) significantly reduced the expression of TNFα and IL-6 but markedly increased the expression of IL-10 [2]. |
| Synonyms | IBS-008738 |
| Molecular Weight | 374.44 |
| Formula | C22H22N4O2 |
| Cas No. | 385425-03-6 |
| Smiles | O=C(C=1C=CC=CC1)C2=C(N=CN2C3=CC=C(C=C3)C)N=CN4CCOCC4 |
| Relative Density. | 1.22 g/cm3 (Predicted) |
| Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 40 mg/mL (106.83 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween-80+45% Saline: 1.5 mg/mL (4.01 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.